Aug 21, 2020 | Clinical Trials, FDA, Globalization, Healthcare, Pharmaceuticals
One of the biggest areas of concern in the pharmaceutical industry, particularly in the United States, is the high costs of new treatments or drug therapies for patients. The recent initiatives from regulatory agencies like the Food and Drug Administration (FDA) to... 
Jun 25, 2020 | Clinical Trials, Healthcare, Pharmaceuticals
With so many cultures, populations, and regulatory variability in Latin America (LATAM), pinning it down to a specific cultural or business practice can be a more sophisticated process than it is in other regions. It is an awe-inspiring mix of Native, African, and... 
Jan 22, 2019 | Clinical Trials, Pharmaceuticals
According to the CDC, 650,000 patients receive chemotherapy every year in the U.S. alone. The side effects are bad enough to cause people to opt into not getting treatment at all. Until now. A new cancer treatment device has been made which reduces the negative... 
Dec 28, 2017 | CFDA, Pharmaceuticals
China is currently recognized as the world second largest pharmaceutical market. However, the regulatory policies have been very challenging for many large foreign pharmaceutical enterprises, as well as innovative local companies. Some of the reasons for those...May 4, 2017 | Pharmaceuticals
This week I want to delve into the unique challenges of translations in the pharmaceutical industry. As with all medical translations, the biggest challenges often come from the difficult nature of industry specific terminology. The pharmaceutical industry continues...
